Trinity Biosystems develops oral therapeutic proteins and vaccines for respiratory, digestive and sexually transmitted diseases.
Business Model:
Revenue: $10M
Employees: 2-10
Address:
City: Menlo Park
State: California
Zip:
Country: United States
Trinity Biosystems, Inc. engages in the development and formulation of oral therapeutic proteins. It involves in developing vaccines in the areas of respiratory, digestive, and sexually transmitted diseases, as well as transporting proteins, peptides, and other macromolecules. The company was founded in 2002 and is based in Menlo Park, California.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2006 | Series B | 4 | $21M |
Amgen Ventures GSK Sanderling Ventures Tenex Greenhouse Ventures Amgen Ventures GSK Sanderling Ventures Tenex Greenhouse Ventures |
11/2009 | Debt Financing | 5 | $7.5M |
Amgen Ventures EQT life science Lilly Ventures Sanderling Ventures SR One Amgen Ventures EQT life science Lilly Ventures Sanderling Ventures SR One |
9/2002 | Series A | 2 | $1.5M |
Sanderling Ventures Tenex Greenhouse Ventures Sanderling Ventures Tenex Greenhouse Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|